Global Recombinant DNA (rDNA) Technology Market: Detailed Analysis, Shares, Size and Forecast Up To 2023

Recombinant DNA (rDNA) Technology Market in

Report Titled on: Recombinant DNA (rDNA) Technology – Global Market Outlook (2017-2023)

The Recombinant DNA (rDNA) Technology Market report provides a detailed analysis of the market segmentation, size, and share; market dynamics such as the growth drivers, restraints, challenges, and opportunities; service providers, investors, stakeholders, and key market players. The report provides detailed profile assessments and multi-scenario revenue projections for the most promising industry participants.

Overview of Recombinant DNA (rDNA) Technology Market: Global Recombinant DNA (rDNA) Technology Market is accounted for $499.8 million in 2016 and expected to grow at a CAGR of 6.9% to reach $799.9 million by 2023.

Factors influencing the market growth are rise in Genetically Modified (GM) crop, development of biofuel and biopesticides, presence of biopharmaceuticals pipeline and production of various therapeutic proteins. Lack of government funding for research and development in emerging economies, risks involved in usage of genetically modified food and regulatory & ethical challenges associated with gene therapy are hampering the market growth.

Purchase full Market Report @

Scope of the Report: Based on component, the Expression systems are used for the production of protein from recombinant DNA molecules. Majorly used expression systems are mammalian, bacterial, insects, and yeast. Development of cell lines such as HEK293 and Chinese Hamster Ovarian (CHO) has contributed to the significant share of mammalian expression system.

Further, , ongoing research to explore the prospective of plant as expression system are expected to underpin the adoption of plans expression system for Genetically Modified product development in the future. Furthermore, more than 3000 scientific studies have been carried out to assess the GM products safety in context to its impact on human health and environment.Based on application, Agricultural plants are one of the most frequently cited cases of genetically modified organisms.

Some benefits of genetic engineering in agriculture are increased crop yields, reduces cost for food or drug production, limited need for pesticides, enhanced nutrient composition and food quality, resistance to pests and disease, with enormous food security, and medical benefits. The advantage of recombinant DNA technology is that new combinations of genes are determined in the forefront. GE has also been used against crop pathogens.

One of the first and most successful genetically modified crops was a papaya with resistance to ringspot virus. Another example includes the development of bananas resistant to wilt in Uganda.North America accounted for the maximum share of the market which attributes to a affluent number of biopharmaceutical manufacturing companies are situated in the U.S. In July 2017, U.S witnessed the 1st FDA approval for gene therapy treatment. The treatment was developed for leukemia disorder, in conjugation between the University of Pennsylvania and Novartis Corp. This, in turn, furtherance the enact of rDNA techniques in the region. Asia Pacific is expected to be the fastest growing market. Clinical trials in Asian countries such as India and China are less expensive compared to other regions which made migration of several biopharmaceutical developers towards this region.

Target Audience of Recombinant DNA (rDNA) Technology Market 2017 Forecast to 2023 Market:

  • Manufacturer / Potential Investors
  • Traders, Distributors, Wholesalers, Retailers, Importers and Exporters.
  • Association and government bodies.

Recombinant DNA (rDNA) Technology market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including:

  • F. Hoffmann-La Roche Ltd
  • Monsanto Company
  • Amgen Inc
  • Biocon
  • Biogen
  • Eli Lilly and Company
  • GenScript
  • GlaxoSmithKline plc
  • Horizon Discovery Group PLC
  • Merck & Co
  • New England Biolabs.
  • Novartis AG
  • Novo Nordisk A/S
  • Pfizer Inc and Profacgen

 And More……

On the basis of product and end users/applications, this report displays the production, revenue, price, Recombinant DNA (rDNA) Technology market share and growth rate of each type, primarily split into: 

Components Covered: Cloning Vector, Phage, Bacterial Artificial Chromosome (BAC), Human Artificial Chromosome (HAC), Yeast Artificial Chromosome (YAC), Cosmid, Plasmid, Expression System, Baculovirus/Insect, Bacteria, Mammalian, Yeast, Other Expression SystemProducts Covered: Non-medical, Specialty Chemicals, Biotech Crops, Other Non-Medical Technology, Medical, Human Protein, Therapeutic Agent, Vaccine

Applications Covered: Health & Disease, Human, Animal, Food & Agriculture, Environment, Other Applications

End Users Covered: Academic & Research Institutes, Pharmaceutical & Biotech Entities, Other End Users

Get Sample PDF of Report with Your Corporate E-mail ID

Recombinant DNA (rDNA) Technology Market 2017 Forecast to 2023 Market Segment by Regions, regional analysis covers

  • North America (USA, Canada and Mexico)
  • Europe (Germany, France, UK, Russia and Italy)
  • Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  • South America (Brazil, Argentina, Columbia etc.)
  • Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Recombinant DNA (rDNA) Technology Market report offers following key points: 

  • Recombinant DNA (rDNA) Technology Market share assessments for the regional and country level segments.
  • Market share analysis of the top industry players.
  • Strategic recommendations for the new entrants.
  • Recombinant DNA (rDNA) Technology Market forecasts for a minimum of 7 yearsof all the mentioned segments, sub segments and the regional markets.
  • Recombinant DNA (rDNA) Technology Market Trends(Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations).
  • Strategic recommendations in key business segmentsbased on the market estimations.
  • Competitive landscaping mapping the key common trends of Recombinant DNA (rDNA) Technology market.
  • Company profiling with detailed strategies, financials, and recent developments.
    Supply chain trends mapping the latest technological advancements.

Ask our Industry Experts @

You May Also Like